Composition for weight reduction containing ephedrine and a mineral salt or chelate
CA 2174422 A1 · Owner: Keown, Wendy J. · Inventors: Ford, Betty J.; Keown, Wendy J.; Stoddard, Sandra L.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A weight reduction composition comprises a sympathomimetic agent and a mineral cation salt or chelate capable of enhancing carbohydrate metabolism, protein or fatty acid synthesis retarding protein breakdown or lowering serum cholesterol levels such as trivalent and hexavalent chromium and vanadium salts and chelates. Preferred is a weight reduction composition containing ephedrine and chromium picolinate. This composition is presented in a variety of formultations and is suitable for application to the reduction of weight of normal slightly and grossly overweight humans.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 21, 1994. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 21, 2014.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 21, 2016.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.